Canopy Growth’s subsidiary, Spectrum Cannabis, will partner with Ontario Long Term Care Association (OLTCA) to develop a medical cannabis pilot study and care pathway for long-term care patients in LTC homes in Ontario.
The Smith Falls, Ontario-based cannabis producer Canopy Growth (TSX: WEED) (NYSE: CGC) said the six-month study will measure how medical cannabis might displace less-desirable therapeutics for pain and cognitive function.
The study will be coordinated by the OLTCA, with Spectrum providing product. This will be one of the world’s first and largest cannabis programs in the long-term care area, with up to 500 participants.
“The pilot study…is the first step in developing an evidence-based…approach to medical cannabis…for seniors and ultimately improve quality of life…in long-term care homes,” ” said Mark Zekulin, President & Co-CEO, Canopy Growth.
Spectrum aims to simplify medical cannabis for patients and practitioners. Founded in Canada, it operates in Australia, South America, Africa and across Europe. Spectrum’s products include whole flower cannabis, oils and Softgels.
Canopy Growth is a leading diversified cannabis company with over a dozen licensed production sites globally, and over 3.2 million sf of production capacity. It operates in 11 countries on five continents. Canopy has partnerships with Snoop Dogg, breeding firms DNA Genetics and Green House seeds, and Fortune 500 alcohol company Constellation Brands.
The Ontario Long Term Care Association is the largest association of long-term care providers in Canada, representing private, not-for-profit, charitable, and municipal providers. It represents nearly 70% of Ontario’s 630 long-term care homes, and serves over 70,000 residents annually.
Source Canopy press release